Filing Details
- Accession Number:
- 0001628280-24-052603
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-12-30 19:41:52
- Reporting Period:
- 2024-12-02
- Accepted Time:
- 2024-12-30 19:41:52
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1087294 | Cumberland Pharmaceuticals Inc | CPIX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1695580 | Kenneth Krogulski | 1600 West End Ave., Suite 1300 Nashville TN 37203 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-12-02 | 415 | $1.33 | 272,042 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-03 | 415 | $1.26 | 272,457 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-04 | 415 | $1.22 | 272,872 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-05 | 350 | $1.20 | 273,222 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-06 | 415 | $1.20 | 273,637 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-09 | 415 | $1.25 | 274,052 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-10 | 197 | $2.48 | 274,249 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-11 | 197 | $2.29 | 274,446 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-12 | 197 | $2.19 | 274,643 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-13 | 197 | $2.33 | 274,840 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-16 | 312 | $2.21 | 275,152 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-17 | 312 | $2.12 | 275,464 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-18 | 312 | $2.19 | 275,776 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-19 | 266 | $2.33 | 276,042 | No | 5 | P | Direct | |
Common Stock | Acquisiton | 2024-12-20 | 301 | $2.35 | 276,343 | No | 5 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct | |
No | 5 | P | Direct |
Footnotes
- The reported purchases occurred automatically pursuant to a Rulo10b5-1 trading plan adopted by the reporting person on March 13, 2024.